Generic formulation

EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE

1 Uganda record

Browse branded medicines

Active ingredients

emtricitabine + tenofovir disoproxil

Active ingredients: 2
Individual monographs: 3 available
Uganda registered products: 1

Jurisdiction: UGSource: Uganda National Drug Register, July 2024

Individual drug information

Clinical information is kept separate for each active ingredient in this formulation.

emtricitabine

2 reference sources available

Mosby’s 2024 BNF 80 (2020–2021)

tenofovir disoproxil

1 reference source available

BNF 80 (2020–2021)

Combination products do not use one blanket clinical monograph here. Open an ingredient above to read the information extracted for that individual drug.

Uganda registered brands

Products linked to this generic formulation in the National Drug Register.

EMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE TABLETS 200 MG/ 300 MGEMTRICITABINE + TENOFOVIR DISOPROXIL FUMARATE

200MG + 300MG · ORAL SOLID ORDINARY FILM- COATED TABLETS

LAURUS LABS LIMITED -UG · NDA/MAL/HDP/9977

View details

Professional reference only. A Uganda registration record does not confirm current availability or that a product is appropriate for a particular patient. Verify current guidelines, diagnosis, dose, route, contraindications, interactions and regulatory status before prescribing.